Elizabeth B. Lamont, MD, MS; Nicholas A. Christakis, MD, PhD, MPH
Acknowledgments: The authors thank Tammy Polonsky and Ellena Linden for help in administering the survey and Ron Thisted and Melinda Drum for statistical consultation.
Grant Support: By the Soros Foundation Project on Death in America Faculty Scholars Program (Dr. Christakis), the Robert Wood Johnson Clinical Scholars Program034652 (Dr. Lamont), and the National Institutes of Health (K12 AG-0048-09) (Dr. Lamont).
Requests for Single Reprints: Nicholas A. Christakis, MD, PhD, MPH, University of Chicago Medical Center, 5841 South Maryland Avenue, MC 2007, Chicago, IL 60637; e-mail, firstname.lastname@example.org.
Current Author Addresses: Drs. Lamont and Christakis: University of Chicago Medical Center, 5841 South Maryland Avenue, MC 2007, Chicago, IL 60637.
Author Contributions: Conception and design: N.A. Christakis.
Analysis and interpretation of the data: E.B. Lamont, N.A. Christakis.
Drafting of the article: E.B. Lamont, N.A. Christakis.
Critical revision of the article for important intellectual content: E.B. Lamont, N.A. Christakis.
Final approval of the article: E.B. Lamont, N.A. Christakis.
Provision of study materials or patients: N.A. Christakis.
Statistical expertise: E.B. Lamont, N.A. Christakis.
Obtaining of funding: E.B. Lamont, N.A. Christakis.
Administrative, technical, or logistic support: N.A. Christakis.
Collection and assembly of data: E.B. Lamont, N.A. Christakis.
Lamont E., Christakis N.; Prognostic Disclosure to Patients with Cancer near the End of Life. Ann Intern Med. 2001;134:1096-1105. doi: 10.7326/0003-4819-134-12-200106190-00009
Download citation file:
Published: Ann Intern Med. 2001;134(12):1096-1105.
Forty years ago, physicians did not inform most patients with cancer of their diagnoses (1, 2). This practice of nondisclosure is now generally considered out of date, primarily because it may represent physician paternalism that compromises patient autonomy. Indeed, almost all patients with cancer are now informed of their diagnoses (3). Nevertheless, it is not clear how many understand the survival implications, that is, the associated prognosis. Because survival estimates often strongly affect decisions about cancer treatment, especially at the end of life, patients need and often rightly request prognoses when making such decisions (4-7).
to gain full access to the content and tools.
Learn more about subscription options.
Register Now for a free account.
Hematology/Oncology, End-of-Life Care.
Results provided by:
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only